| Transcriptional regulatory model of fibrosis progression in the human lung JE McDonough, F Ahangari, Q Li, S Jain, SE Verleden, J Herazo-Maya, ... JCI insight 4 (22), 2019 | 123 | 2019 |
| Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study LJ De Sadeleer, F Hermans, E De Dycker, J Yserbyt, JA Verschakelen, ... Journal of clinical medicine 8 (1), 14, 2018 | 117 | 2018 |
| Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases LJ De Sadeleer, C Meert, J Yserbyt, H Slabbynck, JA Verschakelen, ... Chest 153 (6), 1416-1423, 2018 | 98 | 2018 |
| Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study SE Verleden, N Tanabe, JE McDonough, DM Vasilescu, F Xu, WA Wuyts, ... The Lancet Respiratory Medicine 8 (6), 573-584, 2020 | 83 | 2020 |
| Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in Fibrotic Hypersensitivity Pneumonitis: a retrospective cohort study LJ De Sadeleer, F Hermans, E De Dycker, J Yserbyt, JA Verschakelen, ... European Respiratory Journal 55 (4), 2020 | 52 | 2020 |
| The aging lung: tissue telomere shortening in health and disease S Everaerts, EJ Lammertyn, DS Martens, LJ De Sadeleer, K Maes, ... Respiratory research 19, 1-10, 2018 | 48 | 2018 |
| Skin exposure contributes to chemical-induced asthma: what is the evidence? A systematic review of animal models HC Tsui, S Ronsmans, LJ De Sadeleer, PHM Hoet, B Nemery, ... Allergy, asthma & immunology research 12 (4), 579, 2020 | 23 | 2020 |
| Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis LJ De Sadeleer, SE Verleden, E De Dycker, J Yserbyt, JA Verschakelen, ... Respirology 23 (12), 1160-1165, 2018 | 19 | 2018 |
| Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis LJ De Sadeleer, JE McDonough, JC Schupp, X Yan, A Vanstapel, ... American journal of respiratory and critical care medicine 205 (1), 60-74, 2022 | 17 | 2022 |
| Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage LJ De Sadeleer, T Goos, J Yserbyt, WA Wuyts Journal of Clinical Medicine 9 (6), 1722, 2020 | 17 | 2020 |
| Distinct airway involvement in subtypes of end-stage fibrotic pulmonary sarcoidosis SE Verleden, A Vanstapel, L De Sadeleer, A Dubbeldam, T Goos, ... Chest 160 (2), 562-571, 2021 | 15 | 2021 |
| Prevalence of myositis-specific antibodies in idiopathic interstitial pneumonias LJ De Sadeleer, E De Langhe, N Bodart, A Vigneron, X Bossuyt, ... Lung 196, 329-333, 2018 | 15 | 2018 |
| Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review S Bos, LJ De Sadeleer, A Vanstapel, H Beeckmans, A Sacreas, J Yserbyt, ... European Respiratory Review 30 (160), 2021 | 14 | 2021 |
| Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts CH Mayr, A Sengupta, S Asgharpour, M Ansari, JC Pestoni, P Ogar, ... European Respiratory Journal 63 (2), 2024 | 13 | 2024 |
| Beyond bronchiolitis obliterans: in-depth histopathologic characterization of bronchiolitis obliterans syndrome after lung transplantation A Vanstapel, SE Verleden, EK Verbeken, P Braubach, T Goos, ... Journal of clinical medicine 11 (1), 111, 2021 | 13 | 2021 |
| Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be T Goos, LJ De Sadeleer, J Yserbyt, GM Verleden, M Vermant, ... Journal of Clinical Medicine 10 (6), 1330, 2021 | 13 | 2021 |
| Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis EM Lambert, WA Wuyts, J Yserbyt, LJ De Sadeleer Respiratory Medicine 176, 106259, 2021 | 13 | 2021 |
| Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival A Vanstapel, SE Verleden, B Weynand, E Verbeken, L De Sadeleer, ... European Respiratory Journal 56 (3), 2020 | 11 | 2020 |
| Quantitative analysis of airway obstruction in lymphangioleiomyomatosis SE Verleden, A Vanstapel, L De Sadeleer, B Weynand, M Boone, ... European Respiratory Journal 56 (1), 2020 | 11 | 2020 |
| BAL transcriptomes characterize idiopathic pulmonary fibrosis endotypes with prognostic impact LJ De Sadeleer, SE Verleden, JC Schupp, JE McDonough, T Goos, ... Chest 161 (6), 1576-1588, 2022 | 10 | 2022 |
